Protease Inhibitor Market - Global Industry Size, Top Key Players, Drivers and Forecast to 2022
Global Protease Inhibitor Market, on the
basis of geography, is segmented into Asia Pacific, Latin America, Europe,
North America and Middle East & Africa. Protease inhibitors (PIs) are a
class of antiviral drugs that are widely used to treat HIV/AIDS and hepatitis
C. Protease inhibitors prevent viral replication selectively binding to viral
proteases and blocking proteolytic cleavage of protein precursors that are
necessary for the production of infectious viral particles. Protease inhibitors
bind to the active site of the protease enzyme and prevent the maturation of
the newly produced virions so that they remain non-infectious. Protease
inhibitors are used in the treatment of human immunodeficiency virus (HIV
infection) and acquired immune deficiency syndrome (AIDS).In addition, there
are many more proteases found in viruses, bacteria and parasites which are also
potential drug targets.
View Full Report
with TOC @ https://www.millioninsights.com/industry-reports/protease-inhibitor-pi-market
Factors such as rising
incidences of HIV, Aids and immune related problems propelled the market growth
in the predicted period. Also, the rise in medical infrastructure and rise in
diagnostic measures also contributed to the market growth. Proteases comprise drug targets for HIV and
the clotting cascade as well as degradative enzymes such as elastase and
dipeptidyl peptidases such as DPP IV. Many viral, bacterial and parasitic
proteases are also potential drug targets and due to their lower homology to
their mammalian orthologs, offer target opportunities to identify selective
inhibitors that have minimal cross-reactivity with mammalian proteases.
Geographically, the global
protease inhibitor market spans North America, Latin America, Europe,
Asia-Pacific, Middle-East & Africa. North America dominated the global
market owing to rising prevalence of AIDS and immune related problems. APAC
market also anticipated in significant growth in the global market owing The key players in the protease inhibitor
market include CSL Ltd., Grifols S.A, Baxalta Incorporated, Octapharma AG,
KedrionS.p.A, China Biologic Products Inc., Biotest AG, LFB S.A, Bio Product
Laboratory Ltd. and Sanquin.
Request Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/protease-inhibitor-pi-market/request-sample
Comments
Post a Comment